methyl 5-aminolevulinate has been researched along with Pain in 51 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 9 (17.65) | 29.6817 |
2010's | 40 (78.43) | 24.3611 |
2020's | 2 (3.92) | 2.80 |
Authors | Studies |
---|---|
Gillstedt, M; Salah, L; Sandberg, C; Sjöholm, A; Tovi, J; Wennberg Larkö, AM; Wojewoda, K | 1 |
Lecamwasam, K; Levell, NJ; Skellett, AM | 1 |
Gonzalez, H; Haedersdal, M; Halldin, C; Sandberg, C; Sørensen, SS; Togsverd-Bo, K; Wennberg, AM; Wulf, HC | 1 |
de Haas, ERM; Kelleners-Smeets, NWJ; Kessels, JPHM; Kreukels, H; Mosterd, K; Nelemans, PJ; Roozeboom, MH; van Pelt, H | 1 |
Festa-Neto, C; Grinblat, B; Haedersdal, M; Szeimies, RM; Torezan, L; Valente, N | 1 |
Philipp-Dormston, WG | 1 |
Szeimïes, RM | 1 |
Dirschka, T; Novak, B; Rybarski, M; Schmitz, L | 1 |
Beneton, N; Hainaut, E; Martin, L; Misery, L; Quereux, G; Rioli, DI; Samimi, M | 1 |
Bancalari, E; Bernia, E; Calomarde, L; Diago, A; Guillén, C; Kindem, S; Llombart, B; Nagore, E; Requena, C; Sanmartín, O; Serra-Guillén, C; Serra-Guillén, I | 1 |
Mei, X; Wang, L; Zhang, R; Zhong, S | 1 |
Fargnoli, MC; Gutiérrez García-Rodrigo, C; Pellegrini, C; Piccioni, A; Tambone, S | 1 |
Arbustini, E; Borroni, RG; Brazzelli, V; Carugno, A; Rivetti, N | 1 |
Barge, J; Kasraee, B; Piffaretti, F; Salomon, D; van den Bergh, H; Wagnières, G; Zellweger, M | 1 |
Basset-Seguin, N | 1 |
Bosc, C; Foley, P; Hewitt, D; Kerob, D; Kerrouche, N; Murrell, DF; Rubel, DM; See, JA; Shumack, S; Spelman, L; Wulf, HC | 1 |
Erlendsson, AM; Hædersdal, M; Lei, U; Philipsen, PA; Skov, L; Taudorf, EH; Togsverd-Bo, K; Wulf, HC | 1 |
Petersen, B; Wiegell, SR; Wulf, HC | 2 |
Graf, B; Gruber, M; Hansen, E; Heinlin, J; Horner, C; Karrer, S; Kerscher, C; Klein, A; Koller, M; Landthaler, M; Szeimies, RM; Werner, A; Zeman, F | 1 |
Falto-Aizpurua, L; Griffith, RD; Nouri, K; Yazdani Abyaneh, MA | 1 |
Fargnoli, MC; Neri, L; Pellegrini, C; Peris, K; Piccioni, A; Tambone, S | 1 |
Fabricius, S; Lerche, CM; Philipsen, PA; Wulf, HC | 1 |
Grönroos, M; Neittaanmäki, E; Neittaanmäki-Perttu, N; Pölönen, I; Snellman, E | 1 |
Adamski, H; Basset-Seguin, N; Dreno, B; Gerritsen, MJ; Gilaberte, Y; Girard, C; Kelleners-Smeets, N; Kerrouche, N; Lacour, JP; Leclerc, S; Perez-Garcia, B; Redondo, P; Serra-Guillen, C; Synnerstad, I; Szeimies, RM; Tarstedt, M; Tsianakas, A; Ulrich, C; Venema, AW; Von Felbert, V | 1 |
Kelleners-Smeets, NW; Kessels, JP; Krekels, GA; Mosterd, K; Nelemans, PJ; Ostertag, JU | 1 |
Berneburg, M | 1 |
Berking, C; Dirschka, T; Gerber, PA; Hunger, RE; Karrer, S; Lonsdorf, AS; Petering, H; Philipp-Dormston, WG; Radakovic, S; Szeimies, RM; Ulrich, C | 1 |
Bukhalo, M; Eichenfield, LF; Jarratt, M; Pariser, DM; Waterman, G | 1 |
Adamski, H; Basset-Séguin, N; Beaulieu, P; Dreno, B; Girard, C; Lacour, JP; Riboulet, JL | 1 |
Heerfordt, IM; Mikkelsen, CS; Nissen, CV; Wiegell, SR; Wulf, HC | 1 |
Hambly, RA; Lenane, P; Mansoor, N; Moloney, FJ; Quinlan, C; Ralph, N; Shah, Z | 1 |
Arpaia, N; Cassano, N; Fai, D; Romano, I; Vena, GA; Vestita, M | 1 |
Babilas, P; Karrer, S; Landthaler, M; Schreml, S; Steinbauer, JM; Szeimies, RM; Zeman, F | 1 |
Abuzahra, F; Braathen, LR; Hoff-Lesch, S; Hoffmann, G; Merk, HF; Renn, CN; von Felbert, V | 1 |
Denk, K; Enk, A; Gholam, P; Hartmann, M; Sehr, T | 1 |
Fernández-Guarino, M; García-Morales, I; Harto, A; Jaén, P | 1 |
Goldman, MP; Palm, MD | 1 |
Attili, SK; Dawe, R; Ibbotson, S | 1 |
Berking, C; Borrosch, F; Brüning, H; Deichmann, M; Dirschka, T; Dominicus, R; Foguet, M; Gröne, D; Helwig, C; Hofbauer, G; Hönigsmann, H; Hübinger, F; Jenne, L; Karl, L; Klövekorn, W; Krähn-Senftleben, G; Lehmann, P; Lübbert, H; Mensing, H; Moers-Carpi, M; Oster-Schmidt, C; Radny, P; Reich, K; Reinhold, U; Schmitz, B; Sebastian, M; Simon, M; Szeimies, RM; Tanner, M; Wernicke-Panten, K; Wolf, P | 1 |
Baltás, E; Gaál, M; Gyulai, R; Kemény, L; Ocsai, H; Oláh, J; Otrosinka, S | 1 |
Anderson, RR; Haak, CS; Hædersdal, M; Hædesdal, M; Thaysen-Petersen, D; Togsverd-Bo, K; Wulf, HC | 1 |
Hearn, R; Ibbotson, SH; Valentine, R | 1 |
Hong, JS; Jung, JY; Suh, DH; Yoon, JY | 1 |
Wennberg, AM | 1 |
Foley, P | 1 |
Wiegell, SR; Wulf, HC | 1 |
Hein, R; Kasche, A; Luderschmidt, S; Ring, J | 1 |
Haedersdal, M; Philipsen, PA; Skiveren, J; Wiegell, SR; Wulf, HC | 1 |
Haedersdal, M; Togsverd-Bo, K; Wiegell, SR; Wulf, HC | 1 |
Ericson, MB; Halldin, CB; Paoli, J; Sandberg, C; Wennberg, AM | 1 |
10 review(s) available for methyl 5-aminolevulinate and Pain
Article | Year |
---|---|
Segmental porokeratosis responding to methyl aminolevulinate photodynamic therapy.
Topics: Aftercare; Aged; Aminolevulinic Acid; Humans; Male; Pain; Photochemotherapy; Porokeratosis; Pruritus; Treatment Outcome | 2020 |
Photodynamic therapy for aesthetic-cosmetic indications.
Topics: Aminolevulinic Acid; Humans; Keratosis, Actinic; Light; Pain; Photochemotherapy; Photosensitizing Agents; Rejuvenation; Skin Aging; Time Factors; Treatment Outcome | 2018 |
Pain perception during photodynamic therapy: why is daylight PDT with methyl aminolevulinate almost pain-free? A review on the underlying mechanisms, clinical reflections and resulting opportunities.
Topics: Aminolevulinic Acid; Humans; Light; Pain; Pain Perception; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms | 2018 |
Daylight photodynamic therapy for field cancerization: lessons from molecular biology.
Topics: Aminolevulinic Acid; Carcinoma, Squamous Cell; Humans; Keratosis, Actinic; Light; Pain; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome | 2018 |
Daylight versus conventional photodynamic therapy for the treatment of actinic keratosis: A meta-analysis of randomized controlled trials.
Topics: Aminolevulinic Acid; Humans; Keratosis, Actinic; Pain; Photochemotherapy; Photosensitizing Agents; Randomized Controlled Trials as Topic; Severity of Illness Index; Sunlight | 2019 |
[PDT panoramic view. Principle, photosensitizers, light sources and validated indications in dermatology].
Topics: Aminolevulinic Acid; Bowen's Disease; Carcinoma, Basal Cell; Clinical Trials as Topic; Humans; Keratosis, Actinic; Pain; Photochemotherapy; Photosensitizing Agents; Practice Guidelines as Topic; Precancerous Conditions; Skin Diseases; Skin Neoplasms | 2013 |
Photodynamic therapy for actinic cheilitis: a systematic review.
Topics: Aminolevulinic Acid; Cheilitis; Esthetics; Humans; Pain; Photochemotherapy; Photosensitizing Agents; Precancerous Conditions; Treatment Outcome | 2015 |
Daylight PDT with MAL - current data and practical recommendations of an expert panel.
Topics: Aminolevulinic Acid; Evidence-Based Medicine; Germany; Humans; Keratosis, Actinic; Light; Pain; Photochemotherapy; Photosensitizing Agents; Practice Guidelines as Topic; Treatment Outcome | 2015 |
A review of pain experienced during topical photodynamic therapy--our experience in Dundee.
Topics: Administration, Topical; Aminolevulinic Acid; Comorbidity; Female; Humans; Male; Pain; Pain Measurement; Photochemotherapy; Photosensitizing Agents; Prevalence; Retrospective Studies; Risk Assessment; Risk Factors; Skin Neoplasms; United Kingdom | 2011 |
Pain, pain relief and other practical issues in photodynamic therapy.
Topics: Administration, Topical; Aminolevulinic Acid; Analgesia; Humans; Pain; Patient Education as Topic; Photochemotherapy; Photosensitizing Agents; Skin Diseases | 2005 |
26 trial(s) available for methyl 5-aminolevulinate and Pain
Article | Year |
---|---|
Optimizing treatment of acne with photodynamic therapy (PDT) to achieve long-term remission and reduce side effects. A prospective randomized controlled trial.
Topics: Acne Vulgaris; Adolescent; Adult; Aminolevulinic Acid; Female; Humans; Light; Male; Pain; Photochemotherapy; Photosensitizing Agents; Placebo Effect; Treatment Outcome; Young Adult | 2021 |
Photodynamic therapy is more effective than imiquimod for actinic keratosis in organ transplant recipients: a randomized intraindividual controlled trial.
Topics: Aged; Aminolevulinic Acid; Drug Eruptions; Facial Dermatoses; Female; Hand Dermatoses; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Pain; Photochemotherapy; Photosensitizing Agents; Scalp Dermatoses; Treatment Outcome | 2018 |
Treatment of superficial basal cell carcinoma by topical photodynamic therapy with fractionated 5-aminolaevulinic acid 20% vs. two-stage topical methyl aminolaevulinate: results of a randomized controlled trial.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Female; Humans; Male; Middle Aged; Pain; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Single-Blind Method; Skin Neoplasms; Treatment Outcome | 2018 |
A randomized split-scalp study comparing calcipotriol-assisted methyl aminolaevulinate photodynamic therapy (MAL-PDT) with conventional MAL-PDT for the treatment of actinic keratosis.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Calcitriol; Dermatologic Agents; Drug Therapy, Combination; Follow-Up Studies; Humans; Keratosis, Actinic; Male; Middle Aged; Pain; Pain Measurement; Photochemotherapy; Photosensitizing Agents; Scalp Dermatoses; Skin; Treatment Outcome | 2018 |
A randomized intraindividual comparative study of methyl-5-aminolaevulinate vs. 5-aminolaevulinic acid nanoemulsion (BF-200 ALA) in photodynamic therapy for actinic keratosis of the face and scalp.
Topics: Administration, Cutaneous; Aged; Aminolevulinic Acid; Erythema; Face; Female; Humans; Keratosis, Actinic; Male; Pain; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Scalp; Skin; Treatment Outcome; Visual Analog Scale | 2018 |
Single versus two-treatment schedule of methyl aminolevulinate daylight photodynamic therapy for actinic keratosis of the face and scalp: An intra-patient randomized trial.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Drug Administration Schedule; Face; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Pain; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Prospective Studies; Scalp; Sunlight | 2019 |
Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminolevulinic Acid; Facial Dermatoses; Female; Humans; Keratosis, Actinic; Male; Ointments; Pain; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Scalp Dermatoses; Treatment Outcome | 2014 |
Combination of ablative fractional laser and daylight-mediated photodynamic therapy for actinic keratosis in organ transplant recipients - a randomized controlled trial.
Topics: Aged; Aminolevulinic Acid; Combined Modality Therapy; Female; Humans; Keratosis, Actinic; Laser Therapy; Male; Middle Aged; Pain; Photochemotherapy; Photosensitivity Disorders; Photosensitizing Agents; Transplant Recipients; Treatment Outcome | 2015 |
Topical corticosteroid reduces inflammation without compromising the efficacy of photodynamic therapy for actinic keratoses: a randomized clinical trial.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminolevulinic Acid; Anti-Inflammatory Agents; Clobetasol; Erythema; Facial Dermatoses; Female; Fluoroscopy; Glucocorticoids; Humans; Keratosis, Actinic; Male; Pain; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Scalp Dermatoses; Treatment Outcome | 2014 |
Comparing cold-air analgesia, systemically administered analgesia and scalp nerve blocks for pain management during photodynamic therapy for actinic keratosis of the scalp presenting as field cancerization: a randomized controlled trial.
Topics: Administration, Oral; Aged; Aminolevulinic Acid; Analgesia; Analgesics, Opioid; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Cold Temperature; Dipyrone; Facial Dermatoses; Forehead; Hemodynamics; Humans; Injections, Intravenous; Keratosis, Actinic; Male; Middle Aged; Nerve Block; Ophthalmic Nerve; Pain; Pain Measurement; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Pirinitramide; Quality of Life; Scalp; Scalp Dermatoses; Trochlear Nerve | 2015 |
Safety of Novel Amino-5-laevulinate Photosensitizer Precursors in Photodynamic Therapy for Healthy Human Skin.
Topics: Administration, Cutaneous; Adult; Aminolevulinic Acid; Double-Blind Method; Erythema; Healthy Volunteers; Humans; Pain; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Prodrugs; Skin; Time Factors | 2016 |
Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Europe; Facial Dermatoses; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Pain; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Scalp Dermatoses; Severity of Illness Index; Single-Blind Method; Skin Cream; Sunlight; Treatment Outcome | 2015 |
Laser-mediated Photodynamic Therapy: An Alternative Treatment for Actinic Keratosis?
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Female; Humans; Keratosis, Actinic; Lasers, Dye; Low-Level Light Therapy; Male; Middle Aged; Pain; Pain Measurement; Patient Preference; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Remission Induction; Severity of Illness Index; Time Factors; Treatment Outcome | 2016 |
Photodynamic therapy with methyl aminolaevulinate 80 mg g(-1) for severe facial acne vulgaris: a randomized vehicle-controlled study.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Aminolevulinic Acid; Child; Double-Blind Method; Drug Eruptions; Facial Dermatoses; Female; Humans; Male; Ointments; Pain; Photochemotherapy; Photosensitizing Agents; Treatment Outcome; Young Adult | 2016 |
Pulse photodynamic therapy reduces inflammation without compromising efficacy in the treatment of multiple mild actinic keratoses of the face and scalp: a randomized clinical trial.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Erythema; Facial Dermatoses; Female; Fluorescence; Humans; Keratosis, Actinic; Male; Ointments; Pain; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Scalp Dermatoses; Treatment Outcome | 2016 |
Increased protoporphyrin IX accumulation does not improve the effect of photodynamic therapy for actinic keratosis: a randomized controlled trial.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Curettage; Drug Eruptions; Erythema; Female; Fluorescence; Hand Dermatoses; Humans; Keratosis, Actinic; Male; Middle Aged; Pain; Pain Measurement; Photochemotherapy; Photosensitizing Agents; Protoporphyrins | 2017 |
Photodynamic therapy of multiple actinic keratoses: reduced pain through use of visible light plus water-filtered infrared A compared with light from light-emitting diodes.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Double-Blind Method; Female; Filtration; Humans; Infrared Rays; Keratosis, Actinic; Lasers, Semiconductor; Male; Middle Aged; Pain; Pain Measurement; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Water | 2010 |
[Photodynamic therapy for acne: use of the pulsed dye laser and methylaminolevulinate].
Topics: Acne Vulgaris; Adolescent; Aminolevulinic Acid; Combined Modality Therapy; Facial Dermatoses; Female; Humans; Lasers, Dye; Low-Level Light Therapy; Male; Pain; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Shoulder; Sunscreening Agents; Treatment Outcome | 2010 |
Safety and efficacy comparison of blue versus red light sources for photodynamic therapy using methyl aminolevulinate in photodamaged skin.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Cohort Studies; Erythema; Female; Humans; Light; Male; Middle Aged; Pain; Photochemotherapy; Prospective Studies; Skin Aging; Treatment Outcome | 2011 |
Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Female; Gels; Humans; Keratosis, Actinic; Male; Middle Aged; Pain; Pain Measurement; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Treatment Outcome; Young Adult | 2012 |
Intensified photodynamic therapy of actinic keratoses with fractional CO2 laser: a randomized clinical trial.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Humans; Keratosis, Actinic; Laser Therapy; Lasers, Gas; Male; Middle Aged; Pain; Pain Measurement; Photochemotherapy; Photosensitizing Agents; Skin Aging; Treatment Outcome | 2012 |
Acne treatment by methyl aminolevulinate photodynamic therapy with red light vs. intense pulsed light.
Topics: Acne Vulgaris; Adult; Aminolevulinic Acid; Color; Female; Humans; Intense Pulsed Light Therapy; Male; Pain; Photochemotherapy; Photosensitizing Agents; Young Adult | 2013 |
Photodynamic therapy of acne vulgaris using methyl aminolaevulinate: a blinded, randomized, controlled trial.
Topics: Acne Vulgaris; Adult; Aminolevulinic Acid; Double-Blind Method; Female; Humans; Male; Pain; Photochemotherapy; Photosensitizing Agents; Severity of Illness Index; Treatment Outcome | 2006 |
Photodynamic therapy induces less pain in patients treated with methyl aminolevulinate compared to aminolevulinic acid.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Female; Humans; Keratosis; Male; Middle Aged; Ointments; Pain; Pain Measurement; Patient Dropouts; Photochemotherapy; Photosensitizing Agents; Scalp Dermatoses; Treatment Outcome | 2006 |
Morphine gel 0.3% does not relieve pain during topical photodynamic therapy: a randomized, double-blind, placebo-controlled study.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Double-Blind Method; Gels; Humans; Keratosis; Middle Aged; Morphine; Pain; Photochemotherapy; Photosensitivity Disorders; Receptors, Opioid; Skin Neoplasms | 2006 |
Long-pulsed dye laser versus long-pulsed dye laser-assisted photodynamic therapy for acne vulgaris: A randomized controlled trial.
Topics: Acne Vulgaris; Adult; Aminolevulinic Acid; Edema; Erythema; Female; Fluorescence; Humans; Laser Therapy; Male; Pain; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Skin Diseases; Treatment Outcome | 2008 |
15 other study(ies) available for methyl 5-aminolevulinate and Pain
Article | Year |
---|---|
Efficacy and tolerance of photodynamic therapy for vulvar Paget's disease: a multicentric retrospective study.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Pain; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Treatment Outcome; Vulvar Neoplasms | 2018 |
Risk of acute postoperative hypertension after topical photodynamic therapy for non-melanoma skin cancer.
Topics: Age Factors; Aged; Aged, 80 and over; Aminolevulinic Acid; Blood Pressure; Bowen's Disease; Carcinoma, Basal Cell; Female; Humans; Hypertension; Keratosis, Actinic; Male; Middle Aged; Pain; Photochemotherapy; Photosensitizing Agents; Risk Factors; Skin Neoplasms | 2013 |
Correlation between protoporphyrin IX fluorescence intensity, photobleaching, pain and clinical outcome of actinic keratosis treated by photodynamic therapy.
Topics: Aged; Aminolevulinic Acid; Fluorescence; Humans; Keratosis, Actinic; Middle Aged; Pain; Pain Measurement; Photobleaching; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Treatment Outcome | 2013 |
Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: an intra-patient, prospective, comparison study in Italy.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Facial Dermatoses; Female; Humans; Italy; Keratosis, Actinic; Male; Middle Aged; Pain; Pain Measurement; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Recurrence; Scalp Dermatoses; Skin Cream; Sunlight; Sunscreening Agents; Temperature | 2015 |
Correlation between treatment time, photobleaching, inflammation and pain after photodynamic therapy with methyl aminolevulinate on tape-stripped skin in healthy volunteers.
Topics: Adult; Aminolevulinic Acid; Erythema; Fluorescence; Forearm; Humans; Inflammation; Male; Middle Aged; Pain; Photobleaching; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Skin; Skin Pigmentation; Time Factors; White People; Young Adult | 2015 |
[Not Available].
Topics: Aminolevulinic Acid; Evidence-Based Medicine; Humans; Keratosis, Actinic; Pain; Photochemotherapy; Photosensitizing Agents; Treatment Outcome | 2015 |
[Procedure for daylight methyl aminolevulinate photodynamic therapy to treat actinic keratoses].
Topics: Aminolevulinic Acid; Clinical Protocols; Facial Dermatoses; Humans; Keratosis, Actinic; Pain; Patient Education as Topic; Photochemotherapy; Photosensitizing Agents; Scalp Dermatoses; Skin Cream; Sunlight; Treatment Outcome | 2016 |
Factors predicting pain and effect of oral analgesia in topical photodynamic therapy.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Analgesics; Bowen's Disease; Carcinoma, Basal Cell; Extremities; Female; Head and Neck Neoplasms; Humans; Keratosis, Actinic; Male; Middle Aged; Pain; Pain Measurement; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Risk Factors; Sex Factors; Skin Neoplasms; Torso | 2017 |
Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: a retrospective analysis of response in 462 patients.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Pain; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Salvage Therapy; Skin Neoplasms; Treatment Outcome | 2009 |
Topical photodynamic therapy with porphyrin precursors--assessment of treatment-associated pain in a retrospective study.
Topics: Age Factors; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Pain; Pain Measurement; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Sex Factors | 2009 |
Factors influencing pain intensity during topical photodynamic therapy of complete cosmetic units for actinic keratoses.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Cosmetic Techniques; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Nerve Endings; Pain; Pain Measurement; Photochemotherapy; Protoporphyrins; Retrospective Studies; Sex Characteristics; Treatment Outcome | 2010 |
Photodynamic therapy of non-melanoma skin cancer with methyl aminolaevulinate is associated with less pain than with aminolaevulinic acid.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Analysis of Variance; Bowen's Disease; Carcinoma, Basal Cell; Extremities; Female; Head; Humans; Keratosis, Actinic; Male; Middle Aged; Pain; Photosensitizing Agents; Skin Neoplasms; Torso | 2012 |
Is the pain of topical photodynamic therapy with methyl aminolevulinate any different from that with 5-aminolaevulinic acid?
Topics: Administration, Topical; Aminolevulinic Acid; Bowen's Disease; Carcinoma, Basal Cell; Humans; Male; Pain; Pain Measurement; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms | 2012 |
Methyl aminolaevulinate photodynamic therapy in practice: treatment protocol.
Topics: Administration, Topical; Aminolevulinic Acid; Clinical Protocols; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Occlusive Dressings; Pain; Photochemotherapy; Photosensitizing Agents; Skin Diseases; Treatment Outcome | 2005 |
Transcutaneous electrical nerve stimulation for pain relief during photodynamic therapy of actinic keratoses.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Humans; Keratosis; Male; Middle Aged; Pain; Pain Measurement; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Transcutaneous Electric Nerve Stimulation | 2008 |